Study: Karuppusamy 2022, Journal of Integrative and Complementary Medicine

Individualized Homeopathic Medicines in Treatment of Vitiligo: Double-Blind, Randomized, Placebo-Controlled Pilot Trial

Citation

Karuppusamy A, Paul S, Chattopadhyay A, et al (2022). Journal of Integrative and Complementary Medicine. PubMed id 35085016.

Open on PubMed

Cards that cite this study (1)

Each card gives its own wording for who was tested, how and what was found.

  • Vitiligo, spread, starting age and treatment options Tier B thin

    B 60 patients with vitiligo at a homeopathy institute in India (n=60)

    Double-blind randomised placebo-controlled pilot trial of individualised homeopathic medicines, 6 months.

    Recruitment and retention were satisfactory and mean reductions in vitiligo and quality-of-life scores were larger with the homeopathic medicines than placebo. The authors conclude only that definitive efficacy trials are warranted.

    As recorded in this card: Karuppusamy A, Paul S, Chattopadhyay A, et al (2022), Journal of Integrative and Complementary Medicine, [primary]

    Note: A feasibility pilot, not an efficacy trial. Results were not tested for statistical significance in the abstract; funding not checked.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.